| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,§
*
Program in Immunology, Departments of
Microbiology and Immunology,
Pediatrics, and
§
Medicine, Stanford University School of Medicine, Stanford, CA 94305;
¶
Children’s Hospital Oakland Research Institute, Oakland, CA 94609; and
||
Department of Human Genetics, Roche Molecular Systems, Alameda, CA 94501
Particular HLA class II allelic sequences are associated with susceptibility to type I diabetes. To understand the mechanism, knowledge of the molecular nature of the specific TCR/peptide/class II interactions involved in the disease process is required. To this end, we have introduced the diabetes-associated human class II HLA-DQ8 allele (DQA1*0301/DQB1*0302) as a transgene into mice and analyzed T cell responses restricted by this molecule to an important Ag in human diabetes, human glutamic acid decarboxylase 65. Hybridomas were used to determine the particular peptides from this Ag presented by HLA-DQ8 to T cells and to map the core minimal epitopes required for T cell stimulation. Analysis of these core epitopes reveals a motif and relevant features for peptides that are immunogenic to T cells when presented by HLA-DQ8. The major immunogenic epitopes of glutamic acid decarboxylase 65 do not contain a negatively charged residue that binds in the P9 pocket of the HLA-DQ8 molecule. PBMC from HLA-DQ8+ diabetic and nondiabetic individuals respond to these peptides, confirming that the mouse model is a useful tool to define epitopes of autoantigens that are processed by human APC and recognized by human T cells.
This article has been cited by other articles:
|
|
 |
|
  X. Ge, J. D. Piganelli, H. M. Tse, S. Bertera, C. E. Mathews, M. Trucco, L. Wen, and W. A. Rudert Modulatory Role of DR4- to DQ8-restricted CD4 T-Cell Responses and Type 1 Diabetes Susceptibility Diabetes, December 1, 2006; 55(12): 3455 - 3462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faideau, E. Larger, F. Lepault, J. C. Carel, and C. Boitard Role of {beta}-Cells in Type 1 Diabetes Pathogenesis Diabetes, December 1, 2005; 54(suppl_2): S87 - S96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Toma, S. Haddouk, J.-P. Briand, L. Camoin, H. Gahery, F. Connan, D. Dubois-Laforgue, S. Caillat-Zucman, J.-G. Guillet, J.-C. Carel, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients PNAS, July 26, 2005; 102(30): 10581 - 10586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Havari, A. M. Lennon-Dumenil, L. Klein, D. Neely, J. A. Taylor, M. F. McInerney, K. W. Wucherpfennig, and M. A. Lipes Expression of the B7.1 Costimulatory Molecule on Pancreatic {beta} Cells Abrogates the Requirement for CD4 T Cells in the Development of Type 1 Diabetes J. Immunol., July 15, 2004; 173(2): 787 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kelemen, P. A. Gottlieb, A. L. Putnam, H. W. Davidson, D. R. Wegmann, and J. C. Hutton HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2{beta}) in Human Prediabetes J. Immunol., March 15, 2004; 172(6): 3955 - 3962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz Directed evolution of a single-chain class II MHC product by yeast display Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity J. Immunol., November 1, 2002; 169(9): 5098 - 5108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Halbout, J.-P. Briand, C. Becourt, S. Muller, and C. Boitard T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse J. Immunol., September 1, 2002; 169(5): 2436 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Y. Arnold, N. L. La Gruta, T. Miller, K. M. Vignali, P. S. Adams, D. L. Woodland, and D. A. A. Vignali The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues J. Immunol., July 15, 2002; 169(2): 739 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Abraham, L. Wen, E. V. Marietta, and C. S. David Type 1 Diabetes-Predisposing MHC Alleles Influence the Selection of Glutamic Acid Decarboxylase (GAD) 65-Specific T Cells in a Transgenic Model J. Immunol., January 15, 2001; 166(2): 1370 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes J. Immunol., December 15, 2000; 165(12): 6748 - 6755. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
